Impact of Balance Training in Community-Dwelling Older Adults After Recovery From COVID-19

January 5, 2026 updated by: Mariam Elsayed Mohamed Abd Alaal, Cairo University

The Impact of Balance Training on Functional Performance and Fall Risk in Community-Dwelling Older Adults Following Recovery From COVID-19"

This research investigates the impact of balance training on improving functional performance and reducing fall risk in community-dwelling older adults who have recovered from COVID-19. Post-COVID-19, many elderly individuals experience lingering physical impairments, including muscle weakness, decreased coordination, and balance deficits, which increase their vulnerability to falls. The study evaluates whether a structured balance training program can enhance stability, mobility, and overall quality of life in this population.

Study Overview

Detailed Description

Older adults recovering from COVID-19 frequently face persistent physical limitations due to the virus's impact on the respiratory, muscular, and neurological systems. These limitations often manifest as impaired balance, reduced functional mobility, and increased risk of falls-conditions further exacerbated by prolonged inactivity or hospitalization during illness.

This research focuses on evaluating the effectiveness of a structured balance training program using The Biodex Stability System in older adults living independently in the community after recovering from COVID-19.

Participants are assessed using validated tools such as the Berg Balance Scale, Timed Up and Go (TUG) test, and The Biodex Stability System to measure changes in balance performance, fall risk, and confidence in daily movement.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • were being older adults (aged ≥60 years), recovered from infection during the last 6 month,

Exclusion Criteria:

  • Individuals were excluded if they have medical history of musculoskeletal trauma or surgery, systemic disease that could affect standing or walking, visual, auditory, or cognitive impairment that preclude the ability to comprehend the instructions during conduction of the study protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The Biodex training
Balance Training
Participants will undergo balance training using the Biodex Balance System plus Traditional balance training
Traditional balance training only
Active Comparator: Control
Traditional Balance Training
Traditional balance training only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biodex Balance indices
Time Frame: Pre and Post 12 weeks
The Biodex Stability System will be used to evaluate dynamic postural stability
Pre and Post 12 weeks
Berg Balance Scale score
Time Frame: Pre and Post 12 weeks
The Berg Balance Scale will be used to evaluate balance capability
Pre and Post 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed up and Go test
Time Frame: Pre and Post 12 weeks
Timed up and Go test will be used to assess functional mobility, dynamic balance, and fall risk in older adults
Pre and Post 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr. Mariam Salem, BMC

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 2, 2025

Primary Completion (Actual)

September 20, 2025

Study Completion (Actual)

October 17, 2025

Study Registration Dates

First Submitted

June 1, 2025

First Submitted That Met QC Criteria

June 1, 2025

First Posted (Actual)

June 4, 2025

Study Record Updates

Last Update Posted (Actual)

January 6, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Community-dwelling Older Adults

Clinical Trials on The Biodex training

Subscribe